Jun 2024 $3 M Private placement after listing $2 to $10 million 1
Mustang Bio, Inc.: Private sale, Jun 2024 × Investors in this round 1 investor had bought by the notice of Jun 24, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $175,931
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James B Murphy · Executive Officer · Interim Chief Financial Officer Manuel B. Litchman, M.D. · Executive Officer, Director · President and Chief Executive Officer Adam J. Chill · Director Lindsay A. Rosenwald, M.D. · Director Michael J. Zelefsky, M.D. · Director Michael S. Weiss · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New York Sold in NY Remarks in the notice On fees: “In connection with the registered direct offering concurrent with the private placement, the placement agent received $175,931 and warrants to purchase up to 367,800 shares of common stock exercisable at $0.5125 per share.”On the amounts: “The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investor and placement agent in the private placement under Rule 506(b).”Signed by Manuel B. Litchman, M.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 24, 2024. Read the notice at the SEC .
options SEC Oct 2023 $5 M Private placement after listing $2 to $10 million 1
Mustang Bio, Inc.: Private sale, Oct 2023 × Investors in this round 1 investor had bought by the notice of Nov 3, 2023: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $308,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Eliot S. Lurier · Executive Officer Manuel S. Litchman, M.D. · Executive Officer, Director Adam J. Chill · Director Lindsay A. Rosenwald, M.D. · Director Michael J. Zelefsky, M.D. · Director Michael S. Weiss · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in NY Remarks in the notice On fees: “In connection with the registered direct offering concurrent with the private placement, the placement agent received $308,000.08 and warrants to purchase up to 155,294 shares of common stock exercisable at $2.125 per share.”On the amounts: “The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investor and placement agent in the private placement under Rule 506(b).”Signed by Matthew Wein, General Counsel. Source: SEC Form D, newest notice filed Nov 3, 2023. Read the notice at the SEC .
equity, options SEC Jan 2017 $95 M No. 6 $50 to $250 million 1,086
Mustang Bio, Inc.: Raise no. 6, Jan 2017 × Investors in this round 1,086 investors had bought by the notice of Feb 15, 2017: 1,086 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $95 M of $100 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $9,478,571
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 15, 2017. Read the notice at the SEC .
equity, options SEC Dec 2016 $39 M No. 5 $10 to $50 million 519
Mustang Bio, Inc.: Raise no. 5, Dec 2016 × Investors in this round 519 investors had bought by the notice of Jan 13, 2017: 519 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $39 M of $70 M offered; $31 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $3,929,688
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 13, 2017. Read the notice at the SEC .
equity, options SEC Dec 2016 $35 M No. 4 $10 to $50 million 437
Mustang Bio, Inc.: Raise no. 4, Dec 2016 × Investors in this round 437 investors had bought by the notice of Jan 13, 2017: 437 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $35 M of $70 M offered; $35 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $3,518,708
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 13, 2017. Read the notice at the SEC .
equity, options SEC Nov 2016 $32 M No. 3 $10 to $50 million 390
Mustang Bio, Inc.: Raise no. 3, Nov 2016 × Investors in this round 390 investors had bought by the notice of Dec 13, 2016: 390 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $32 M of $70 M offered; $38 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $3,208,658
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 13, 2016. Read the notice at the SEC .
equity, options SEC Oct 2016 $20 M No. 2 $10 to $50 million 222
Mustang Bio, Inc.: Raise no. 2, Oct 2016 × Investors in this round 222 investors had bought by the notice of Nov 4, 2016: 222 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $20 M of $70 M offered; $50 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,973,518
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 4, 2016. Read the notice at the SEC .
equity, options SEC Sep 2016 $12 M No. 1 $10 to $50 million 133
Mustang Bio, Inc.: Raise no. 1, Sep 2016 × Investors in this round 133 investors had bought by the notice of Oct 17, 2016: 133 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Mustang Bio, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $12 M of $70 M offered; $58 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,264,641
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael S. Weiss · Executive Officer, Director Lindsay A. Rosenwald · Director Neil A. Herskowitz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New York Sold in all US states Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Michael S. Weiss, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 17, 2016. Read the notice at the SEC .
equity, options SEC